Aine McGovern1, Sarah T Pendlebury1, Nishant K Mishra1, Yuhua Fan1, Terence J Quinn1. 1. From the Department of Academic Geriatric Medicine, NHS Greater Glasgow and Clyde, Glasgow, United Kingdom (A.M.G.); Oxford and Stroke Prevention Research Unit, Nuffield Department of Clinical Neurosciences, Oxford NIHR Biomedical Research Centre, John Radcliffe Hospital, University of Oxford, Oxford, United Kingdom (S.T.P.); Department of Academic Geriatric Medicine, Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, United Kingdom (N.K.M., T.J.Q.); and Department of Neurology, First Affiliated Hospital of Sun Yat-Sen University, Guangdong, China (Y.F.).
Abstract
BACKGROUND AND PURPOSE: Poststroke cognitive assessment can be performed using standardized questionnaires designed for family or care givers. We sought to describe the test accuracy of such informant-based assessments for diagnosis of dementia/multidomain cognitive impairment in stroke. METHODS: We performed a systematic review using a sensitive search strategy across multidisciplinary electronic databases. We created summary test accuracy metrics and described reporting and quality using STARDdem and Quality Assessment of Diagnostic Accuracy Studies (QUADAS) tools, respectively. RESULTS: From 1432 titles, we included 11 studies. Ten papers used the Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE). Four studies described IQCODE for diagnosis of poststroke dementia (n=1197); summary sensitivity: 0.81 (95% confidence interval, 0.60-0.93); summary specificty: 0.83 (95% confidence interval, 0.64-0.93). Five studies described IQCODE as tool for predicting future dementia (n=837); summary sensitivity: 0.60 (95% confidence interval, 0.32-0.83); summary specificity: 0.97 (95% confidence interval, 0.70-1.00). All papers had issues with at least 1 aspect of study reporting or quality. CONCLUSIONS: There is a limited literature on informant cognitive assessments in stroke. IQCODE as a diagnostic tool has test properties similar to other screening tools, IQCODE as a prognostic tool is specific but insensitive. We found no papers describing test accuracy of informant tests for diagnosis of prestroke cognitive decline, few papers on poststroke dementia and all included papers had issues with potential bias.
BACKGROUND AND PURPOSE:Poststroke cognitive assessment can be performed using standardized questionnaires designed for family or care givers. We sought to describe the test accuracy of such informant-based assessments for diagnosis of dementia/multidomain cognitive impairment in stroke. METHODS: We performed a systematic review using a sensitive search strategy across multidisciplinary electronic databases. We created summary test accuracy metrics and described reporting and quality using STARDdem and Quality Assessment of Diagnostic Accuracy Studies (QUADAS) tools, respectively. RESULTS: From 1432 titles, we included 11 studies. Ten papers used the Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE). Four studies described IQCODE for diagnosis of poststroke dementia (n=1197); summary sensitivity: 0.81 (95% confidence interval, 0.60-0.93); summary specificty: 0.83 (95% confidence interval, 0.64-0.93). Five studies described IQCODE as tool for predicting future dementia (n=837); summary sensitivity: 0.60 (95% confidence interval, 0.32-0.83); summary specificity: 0.97 (95% confidence interval, 0.70-1.00). All papers had issues with at least 1 aspect of study reporting or quality. CONCLUSIONS: There is a limited literature on informant cognitive assessments in stroke. IQCODE as a diagnostic tool has test properties similar to other screening tools, IQCODE as a prognostic tool is specific but insensitive. We found no papers describing test accuracy of informant tests for diagnosis of prestroke cognitive decline, few papers on poststroke dementia and all included papers had issues with potential bias.
Authors: Jennifer K Harrison; David J Stott; Rupert McShane; Anna H Noel-Storr; Rhiannon S Swann-Price; Terry J Quinn Journal: Cochrane Database Syst Rev Date: 2016-11-21
Authors: Joanna M Wardlaw; Fergus Doubal; Rosalind Brown; Ellen Backhouse; Lisa Woodhouse; Philip Bath; Terence J Quinn; Thompson Robinson; Hugh S Markus; Richard McManus; John T O'Brien; David J Werring; Nikola Sprigg; Adrian Parry-Jones; Rhian M Touyz; Steven Williams; Yee-Haur Mah; Hedley Emsley Journal: Eur Stroke J Date: 2020-10-11
Authors: Terence J Quinn; Martin Taylor-Rowan; Aishah Coyte; Allan B Clark; Stanley D Musgrave; Anthony K Metcalf; Diana J Day; Max O Bachmann; Elizabeth A Warburton; John F Potter; Phyo Kyaw Myint Journal: Front Neurol Date: 2017-06-13 Impact factor: 4.003
Authors: Sang-Hwa Lee; So Young Park; Min Uk Jang; Yerim Kim; Jungyoup Lee; Chulho Kim; Yeo Jin Kim; Jong-Hee Sohn Journal: Medicina (Kaunas) Date: 2020-06-23 Impact factor: 2.430
Authors: Jennifer K Burton; David J Stott; Rupert McShane; Anna H Noel-Storr; Rhiannon S Swann-Price; Terry J Quinn Journal: Cochrane Database Syst Rev Date: 2021-07-18